Centessa Pharmaceuticals Acquired by Eli Lilly | Healthcare M&A Deal

Eli Lilly has acquired Centessa Pharmaceuticals, a pharmacy business in the United Kingdom, for $38.00. Centessa Pharmaceuticals develops and commercializes medicines in healthcare, strengthening Lilly’s pharmacy acquisition strategy. The Eli Lilly acquisitions expand Lilly’s pipeline and capabilities through a strategic acquisition of a public biopharma platform based in Altrincham, Cheshire. The merger acquisition is announced and structured as a court-sanctioned scheme of arrangement, with healthcare M&A value over $100M and additional consideration of $9.00. Eli Lilly acquires Centessa Pharmaceuticals as a strategic acquisition, targeting a planned close following shareholder approvals and scheduled meetings in June 2026.